Prostate cancer is a global cancer burden and considerable effort has been made through
the years to identify biomarkers for the disease. Approximately a decade ago, the potential of …

Immune checkpoint therapy has achieved significant efficacy by blocking inhibitory
pathways to release the function of T lymphocytes. In the clinic, anti-programmed cell death …

The objective of this systematic review was to analyze the current state of the art of imaging-
derived biomarkers predictive of genetic alterations and immunotherapy targets in lung …

Lung cancer is diagnosed in more than 1.8 million people yearly and remains the leading
cause of cancer deaths in both developing and developed countries, with survival at 5 years …

Liquid biopsy (LB) is a minimally invasive method which aims to detect circulating tumor-
derived components in body fluids. It provides an alternative to current cancer screening …

Liquid biopsies—tests that detect circulating tumor cellular components in the bloodstream—
have the potential to transform cancer by reducing health inequities in screening …

Circulating cell-free DNA (ccfDNA) may contain DNA originating from the tumor in plasma of
cancer patients (ctDNA) and enables noninvasive cancer diagnosis, treatment predictive …

Background: Liquid biopsy (LB) can detect actionable genomic alterations in plasma
circulating tumor circulating tumor DNA beyond tissue testing (TT) alone in advanced non …

Lung cancer is one of the deadliest cancers globally and accounts for most of the cancer-
related deaths in India. Comprehensive data on lung cancer in India are lacking. This review …

The multi-dimensional challenge of drug resistance is one of the pivotal hindrances for
cancer chemotherapy. A reductive approach to define and distinguish the main aspects of …